Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).

Date publication

février 2022

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet , Pr BORG Christophe , Pr BOUCHE Olivier , Dr LAMBERT Aurélien

Tous les auteurs :
Brugel M, Letrillart L, Evrard C, Thierry A, Tougeron D, El Amrani M, Piessen G, Truant S, Turpin A, d'Engremont C, Roth G, Hautefeuille V, Regimbeau JM, Williet N, Schwarz L, Di Fiore F, Borg C, Doussot A, Lambert A, Moulin V, Trelohan H, Bolliet M, Topolscki A, Ayav A, Lopez A, Botsen D, Piardi T, Carlier C, Bouché O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35259629

Résumé

The COVID-19 pandemic caused major oncology care pathway disruption. The CAPANCOVID study aimed to evaluate the impact on pancreatic adenocarcinoma (PA) - from diagnosis to treatment - of the reorganisation of the health care system during the first lockdown.

Mots clés

COVID-19, Cancer, Care pathway, Pancreatic neoplasms, Pandemic, SARS-CoV-2

Référence

Eur J Cancer. 2022 Feb 10;166:8-20